[CPE Cat 3A] Drug safety in pregnancy

For Healthcare Professionals Only.

Introduction

  • Despite advancements, gaps in research persist due to the exclusion of pregnant women from clinical trials, making evidence on drug safety in pregnancy limited.
  • Drug exposure during pregnancy can significantly impact fetal development, with risks varying based on timing, dosage, and drug properties.
  • The thalidomide tragedy in the 1960s led to the establishment of drug regulatory systems to improve safety assessments before marketing.

You must be healthcare professional to view this content.

POMConnect Banner2 Email Bottom

Copyright ยฉ 2025 DocMed Technology Pte Ltd. All rights reserved.